EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieÄquivalenzstudieOpen Access · CC BY 4.0

Effect of tailoring biliopancreatic limb length based on total small bowel length versus standard limb length in one anastomosis gastric bypass: 1-year outcomes of the TAILOR randomized clinical superiority trial

Nienke Slagter iD, Lindsy van der Laan, Loek J M de Heide, Ewoud H Jutte, Mirjam A Kaijser, Stefan L Damen, André P van Beek iD, Marloes Emous

British Journal of Surgery · 30.08.2024 · 111 (9)

DOI: 10.1093/bjs/znae219 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Surgery, online erschienen am 30.08.2024. Verfasst von Nienke Slagter und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Obesity Northern Netherlands, Department of Bariatric and Metabolic Surgery, Medical Center Leeuwarden, Leeuwarden, The Netherlands. Hauptthemen laut MEDLINE: Gastric Bypass, Intestine, Small, Weight Loss. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Center Leeuwarden funded this study. The.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tailoring the biliopancreatic limb length in one anastomosis gastric bypass is proposed as beneficial in retrospective studies, yet randomized trials are lacking. The aim of this double-blind, single-centre RCT was to ascertain whether tailoring biliopancreatic limb length based on total small bowel length (TSBL) results in superior outcomes after one anastomosis gastric bypass compared with a fixed 150 cm biliopancreatic limb length.

Methods

Eligible patients, meeting International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) criteria for metabolic bariatric surgery, scheduled for primary one anastomosis gastric bypass surgery, and willing to be randomized, underwent TSBL measurement during surgery. When TSBL measurement was feasible, patients were randomly assigned to a standard 150 cm biliopancreatic limb length or a tailored biliopancreatic limb based on TSBL: TSBL less than 500 cm, biliopancreatic limb 150 cm; TSBL 500–700 cm, biliopancreatic limb 180 cm; and TSBL greater than 700 cm, biliopancreatic limb 210 cm. The primary outcome was percentage total weight loss at 5 years.

Results

Between September 2020 and August 2022, 212 patients were randomized into the standard biliopancreatic limb group (105 patients) or the tailored biliopancreatic limb group (107 patients). The mean(s.d.) TSBL was 657(128) cm (range 295–1020 cm). In the tailored group, 150, 180, and 210 cm biliopancreatic limb lengths were applied to 8.4%, 53.3%, and 38.3% of patients respectively. The mean(s.d.) 1-year percentage total weight loss was 32.8(6.9)% in the standard group and 33.1(6.2)% in the tailored group (P = 0.787). Nutritional deficiencies and short-term complications showed no significant differences.

Conclusion

Tailoring biliopancreatic limb length based on TSBL is safe and feasible. One year after surgery, it is not superior to a standard biliopancreatic limb length of 150 cm in terms of percentage total weight loss. Registration number Dutch Trial Register, NL7945.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastric BypassIntestine, SmallWeight LossHumansMaleDouble-Blind MethodFemaleAdultMiddle AgedObesity, MorbidAnastomosis, SurgicalTreatment OutcomePancreas

Autor:innen und Institutionen

  • Center for Obesity Northern Netherlands, Department of Bariatric and Metabolic Surgery, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
  • Department of Surgery, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
  • Postgraduate School of Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

ORCID-Profile: Nienke Slagter, André P van Beek

Förderung

  • Medical Center Leeuwarden funded this study. The

Zitieren

APA

Slagter, N., van der Laan, L., de Heide, L. J. M., Jutte, E. H., Kaijser, M. A., Damen, S. L., van Beek, A. P., & Emous, M. (2024). Effect of tailoring biliopancreatic limb length based on total small bowel length versus standard limb length in one anastomosis gastric bypass: 1-year outcomes of the TAILOR randomized clinical superiority trial. British Journal of Surgery, 111(9). https://doi.org/10.1093/bjs/znae219

Vancouver

Slagter N, van der Laan L, de Heide LJM, Jutte EH, Kaijser MA, Damen SL, et al. Effect of tailoring biliopancreatic limb length based on total small bowel length versus standard limb length in one anastomosis gastric bypass: 1-year outcomes of the TAILOR randomized clinical superiority trial. British Journal of Surgery. 2024;111(9). doi:10.1093/bjs/znae219

BibTeX
@article{Slagter2024,
  author = {Slagter, Nienke and van der Laan, Lindsy and de Heide, Loek J M and Jutte, Ewoud H and Kaijser, Mirjam A and Damen, Stefan L and van Beek, André P and Emous, Marloes},
  title = {Effect of tailoring biliopancreatic limb length based on total small bowel length versus standard limb length in one anastomosis gastric bypass: 1-year outcomes of the TAILOR randomized clinical superiority trial},
  journal = {British Journal of Surgery},
  year = {2024},
  volume = {111},
  number = {9},
  doi = {10.1093/bjs/znae219}
}
Kostenlos starten →